Arpa Garay - Net Worth and Insider Trading

Arpa Garay Net Worth

The estimated net worth of Arpa Garay is at least $309,557 dollars as of 2024-02-23. Arpa Garay is the Chief Commercial Officer of Moderna Inc and owns about 3,113 shares of Moderna Inc (MRNA) stock worth over $309,557. Details can be seen in Arpa Garay's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arpa Garay has not made any transactions after 2023-09-06 and currently still holds the listed stock(s).

Transaction Summary of Arpa Garay


Arpa Garay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arpa Garay owns 3 companies in total, including Merck & Co Inc () , Merck & Co Inc () , and Moderna Inc () .

Click here to see the complete history of Arpa Garay’s form 4 insider trades.

Insider Ownership Summary of Arpa Garay

Ticker Comapny Transaction Date Type of Owner
Merck & Co Inc 2022-02-28 SVP Human Health Global Mktg.
Merck & Co Inc 2022-02-28 SVP Human Health Global Mktg.
Moderna Inc 2023-09-06 Chief Commercial Officer

Arpa Garay Latest Holdings Summary

Arpa Garay currently owns a total of 1 stock. Arpa Garay owns 3,113 shares of Moderna Inc (MRNA) as of September 6, 2023, with a value of $309,557.

Latest Holdings of Arpa Garay

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MRNA Moderna Inc 2023-09-06 3,113 99.44 309,557

Holding Weightings of Arpa Garay

Arpa Garay Form 4 Trading Tracker

According to the SEC Form 4 filings, Arpa Garay has made a total of 2 transactions in Moderna Inc (MRNA) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Moderna Inc is the sale of 574 shares on September 6, 2023, which brought Arpa Garay around $62,222.

Insider Trading History of Arpa Garay

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Arpa Garay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Arpa Garay Ownership Network

Ownership Network List of Arpa Garay

No Data

Ownership Network Relation of Arpa Garay

Arpa Garay Owned Company Details

What does Merck & Co Inc do?

Who are the key executives at Merck & Co Inc?

Arpa Garay is the SVP Human Health Global Mktg. of Merck & Co Inc. Other key executives at Merck & Co Inc include Evp & Global Svcs & CFO Robert M Davis , EVP & CFO Caroline Litchfield , and President & Human Health Int?l Joseph Romanelli .

Merck & Co Inc () Insider Trades Summary

Over the past 18 months, Arpa Garay made no insider transaction in Merck & Co Inc (). Other recent insider transactions involving Merck & Co Inc () include a net sale of 133,401 shares made by Steven Mizell , a net sale of 72,029 shares made by Johannes Jacobus Oosthuizen , and a net sale of 5,715 shares made by Joseph Romanelli .

In summary, during the past 3 months, insiders sold 309,424 shares of Merck & Co Inc () in total and bought 0 shares, with a net sale of 309,424 shares. During the past 18 months, 3,968,347 shares of Merck & Co Inc () were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,967,938 shares.

Merck & Co Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.


Merck & Co Inc Insider Transactions

No Available Data

Arpa Garay Mailing Address

Above is the net worth, insider trading, and ownership report for Arpa Garay. You might contact Arpa Garay via mailing address: 2000 Galloping Hill Rd, Kenilworth Nj 07033.

Discussions on Arpa Garay

No discussions yet.